Sukhtian Ghiath M. - 12 Aug 2026 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: OTLK
Reported as of: 12 Aug 2026
Net transaction value: +$2,499,999
SEC form: 4
Accepted by SEC: 14 Aug 2026, 19:52:49 UTC
Prior SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Ghiath M. Sukhtian, By: Lawrence Kenyon, Attorney-in-Fact

Key filing fact

Sukhtian Ghiath M. filed Form 4 for Outlook Therapeutics, Inc. (OTLK) on 14 Aug 2026.

Key facts

This page summarizes Sukhtian Ghiath M.'s Form 4 filing for Outlook Therapeutics, Inc. (OTLK).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 14 Aug 2026, 19:52.

Change

Previous filing in this sequence was filed on 01 Jun 2026.
Current net transaction value: +$2,499,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001717441 Primary reporting owner

Sukhtian Ghiath M.

Relationship: Director, 10%+ Owner
Address: 7TH CIRCLE, ZAHRAN ST., ZAHRAN PLAZA BUILDING, 4TH FLOOR, AMMAN, JORDAN
Signature: /s/ Ghiath M. Sukhtian, By: Lawrence Kenyon, Attorney-in-Fact
Signature date: 14 Aug 2026

CIK 0001804598

GMS Ventures & Investments

Relationship: Director, 10%+ Owner
Address: C/O INTERTRUST CORP. SVCS. (CAYMAN) LTD., 190 ELGIN AVENUE, GEORGE TOWN, CAYMAN ISLANDS
Signature: /s/ GMS Ventures and Investments, By: Lawrence Kenyon, Attorney-in-Fact
Signature date: 14 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OTLK transaction

Common Stock

Purchase

Transaction value: $2,499,999
Shares: +2,525,252
Change %: +11%
Price: $0.9900
Shares after: 24,617,320
Date: 12 Aug 2026
Ownership: See footnote
Footnotes: F1, F3, F4

OTLK transaction

Common Stock

Purchase

Transaction value: $2,499,999
Shares: +2,525,252
Change %: +11%
Price: $0.9900
Shares after: 24,617,320
Date: 12 Aug 2026
Ownership: See footnote
Footnotes: F1, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OTLK transaction Derivative

Warrants (right to buy)

Purchase

Transaction value
Shares: +2,525,252
Change %
Price: $0.000000^*
Shares after: 2,525,252
Date: 12 Aug 2026
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 2,525,252
Exercise price: $1.10
Footnotes: F1, F2, F3, F4

OTLK transaction Derivative

Warrants (right to buy)

Purchase

Transaction value
Shares: +2,525,252
Change %
Price: $0.000000^*
Shares after: 2,525,252
Date: 12 Aug 2026
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 2,525,252
Exercise price: $1.10
Footnotes: F1, F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On August 12, 2026, the Issuer entered into an underwriting agreement with Piper Sandler & Co. and BTIG, LLC, as representatives of the several underwriters named therein, relating to an underwritten public offering by the Issuer of shares of its common stock and accompanying warrants to purchase shares of common stock at a combined public offering price of $0.99 per share of common stock and accompanying warrant. The offering closed on August 14, 2026. The price reported in Table I above represents the combined public offering price for one share of common stock and one accompanying warrant to purchase one share of common stock; no separate consideration was paid for the accompanying warrants, and accordingly the price of the derivative security reported in Table II above is $0.00.

Footnote F2

The warrants were exercisable immediately upon issuance and expire five years from the date of issuance, on August 14, 2031. The warrants are subject to a beneficial ownership limitation that prohibits exercise to the extent the holder, together with its affiliates and other attribution parties, would beneficially own more than the applicable percentage of the Issuer's outstanding common stock immediately after giving effect to such exercise.

Footnote F3

These securities are held of record by GMS Ventures. Ghiath M. Sukhtian ("Ghiath Sukhtian"), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.

Footnote F4

By virtue of the relationships described above in Footnote 3, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.